Yuyu Pharma, Inc. (KRX:000220)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,680.00
-30.00 (-0.64%)
At close: Jun 5, 2025, 3:30 PM KST

Yuyu Pharma Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Other Revenue
-0-0-0-0-0
Upgrade
Revenue
132,649133,147137,210138,881115,65598,120
Upgrade
Revenue Growth (YoY)
-2.69%-2.96%-1.20%20.08%17.87%7.97%
Upgrade
Cost of Revenue
81,67081,77888,68285,91570,56752,965
Upgrade
Gross Profit
50,97951,36948,52752,96645,08845,155
Upgrade
Selling, General & Admin
34,73634,19037,97243,02837,27032,464
Upgrade
Research & Development
2,9442,7807,1888,6204,0084,123
Upgrade
Other Operating Expenses
-52.54212.88219.22221.25258.87196.61
Upgrade
Operating Expenses
39,14638,78849,27653,55943,88838,884
Upgrade
Operating Income
11,83312,582-748.94-592.111,2006,271
Upgrade
Interest Expense
-3,023-3,218-2,554-2,581-2,175-1,759
Upgrade
Interest & Investment Income
1,0691,066990.69605.88216.83210.32
Upgrade
Earnings From Equity Investments
118.9768.58-493.69395.07548.18286.22
Upgrade
Currency Exchange Gain (Loss)
-35.83-150.09-23.86-478.1256.72-198.24
Upgrade
Other Non Operating Income (Expenses)
-1,407-892.12-2,592-852.87-87.18-1,217
Upgrade
EBT Excluding Unusual Items
8,5559,456-5,422-3,503-240.683,593
Upgrade
Gain (Loss) on Sale of Investments
-356.41-370.71657.78182.69-139.24-110.35
Upgrade
Gain (Loss) on Sale of Assets
-45.341,24963.45-46.08-3.23282.15
Upgrade
Asset Writedown
-349.46-349.46-741.5-444.09--53.65
Upgrade
Pretax Income
7,8049,985-5,442-3,810-383.163,711
Upgrade
Income Tax Expense
91.41-304.6798.44615.02537.131,299
Upgrade
Earnings From Continuing Operations
7,71310,289-5,541-4,425-920.292,413
Upgrade
Minority Interest in Earnings
-1,576-1,569-1,640-1,562-1,294-1,129
Upgrade
Net Income
6,1378,720-7,181-5,988-2,2141,284
Upgrade
Preferred Dividends & Other Adjustments
1,1451,145-878.27284.89284.89284.89
Upgrade
Net Income to Common
4,9927,575-6,303-6,273-2,499998.63
Upgrade
Net Income Growth
------72.82%
Upgrade
Shares Outstanding (Basic)
161616171612
Upgrade
Shares Outstanding (Diluted)
171716171612
Upgrade
Shares Change (YoY)
4.42%3.29%-1.89%3.90%32.81%-19.87%
Upgrade
EPS (Basic)
305.85468.10-387.43-378.31-156.5783.10
Upgrade
EPS (Diluted)
305.85462.90-387.43-378.31-157.0083.00
Upgrade
EPS Growth
------77.94%
Upgrade
Free Cash Flow
20,75417,838-4,094-11,512-1,565-14,716
Upgrade
Free Cash Flow Per Share
1225.031061.56-251.63-694.28-98.04-1224.65
Upgrade
Gross Margin
38.43%38.58%35.37%38.14%38.98%46.02%
Upgrade
Operating Margin
8.92%9.45%-0.55%-0.43%1.04%6.39%
Upgrade
Profit Margin
3.76%5.69%-4.59%-4.52%-2.16%1.02%
Upgrade
Free Cash Flow Margin
15.65%13.40%-2.98%-8.29%-1.35%-15.00%
Upgrade
EBITDA
17,46618,2484,8584,4355,70310,170
Upgrade
EBITDA Margin
13.17%13.71%3.54%3.19%4.93%10.37%
Upgrade
D&A For EBITDA
5,6335,6665,6075,0274,5033,899
Upgrade
EBIT
11,83312,582-748.94-592.111,2006,271
Upgrade
EBIT Margin
8.92%9.45%-0.55%-0.43%1.04%6.39%
Upgrade
Effective Tax Rate
1.17%----34.99%
Upgrade
Advertising Expenses
-2,6954,4817,1196,1314,382
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.